Chromocell Therapeutics Corp (CHRO)
1.99
-0.18
(-8.29%)
USD |
NYAM |
May 15, 16:00
1.99
0.00 (0.00%)
After-Hours: 16:16
Chromocell Therapeutics Total Assets (Quarterly): 0.0228M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.0228M |
| June 30, 2023 | 0.0819M |
| March 31, 2023 | 0.0486M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0551M |
| September 30, 2022 | 44.46M |
| December 31, 2021 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
44.46M
Maximum
Sep 2022
7.445M
Average
0.0518M
Median
Total Assets (Quarterly) Benchmarks
| iBio Inc | 34.02M |
| Lixte Biotechnology Holdings Inc | 4.309M |
| PDS Biotechnology Corp | 59.39M |
| Syros Pharmaceuticals Inc | 168.17M |
| Nutriband Inc | 7.517M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.927M |
| Shareholders Equity (Quarterly) | -5.905M |